E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)
The Centers for Disease Control and Prevention (CDC) is investigating a multistate outbreak of lung injury associated with use of e-cigarette, or vaping, products. Healthcare providers and clinicians should report any suspected cases of EVALI to their local health department.
- DHEC Health Alert Network
- CDC Clinical Outreach and Communication Activity Clinical Action Alert
- Outbreak of Lung Disease Associated with E-Cigarettes, or Vaping (CDC)
- Update: Interim Guidance for Healthcare Providers
The SC Department of Health and Environmental Control (DHEC) is participating in the Centers for Disease Control and Prevention (CDC) investigation of E-cigarette and Vaping Product Use Associated Lung Injury (EVALI) . While recent findings suggest products containing THC play a role in the outbreak, the specific chemical exposure causing the lung injuries remains unknown. It is important to remember that no single product or substance has been linked to all cases. More information is needed to know whether one or more e-cigarette or vaping product, substance, or brand is responsible for the outbreak.
As of October 8, 2019, the CDC is reporting 1,299* lung injury cases associated with using e-cigarette, or vaping, products from 49 states, the District of Columbia, and 1 U.S. territory. Twenty-six deaths have been confirmed in 21 states.
South Carolina is investigating reports of suspected vaping related illness in all four regions of the state. Cases range in age from 17-69. Clinical information regarding cases is provided to DHEC by physicians using CDC approved tools. DHEC in turn provides this information to the CDC, where it is compiled to further the investigation.
|SC Cases of E-Cigarette and Vaping Product Use Associated Lung Injury (EVALI)|
|Confirmed or Probable||24|
Find more e-cigarette risk information on the DHEC E-cigarettes, Vapes, and Other Tobacco Products page.
*The increase in lung injury cases from last week represents both new patients and recent reporting of previously-identified patients to CDC.